Cargando…
The celiac iceberg: from the clinical spectrum to serology and histopathology in children and adolescents with type 1 diabetes mellitus and Down syndrome
Objective: The objective of this study is to investigate the occurrence of gastrointestinal (GI) and extraintestinal symptoms in children and adolescents with type 1 diabetes mellitus (DM1) and Down syndrome (DS) and their association with specific antibodies and histopathology of celiac disease (Ce...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Informa Healthcare
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4732421/ https://www.ncbi.nlm.nih.gov/pubmed/26339731 http://dx.doi.org/10.3109/00365521.2015.1079645 |
_version_ | 1782412699713404928 |
---|---|
author | Costa Gomes, Rosane Cerqueira Maia, Jussara Fernando Arrais, Ricardo André Nunes Jatobá, Carlos Auxiliadora Carvalho Rocha, Maria Edinilma Felinto Brito, Maria Laissa Oliveira Nazion, Ana Marques Maranhão, Clarissa De Sousa Maranhão, Hélcio |
author_facet | Costa Gomes, Rosane Cerqueira Maia, Jussara Fernando Arrais, Ricardo André Nunes Jatobá, Carlos Auxiliadora Carvalho Rocha, Maria Edinilma Felinto Brito, Maria Laissa Oliveira Nazion, Ana Marques Maranhão, Clarissa De Sousa Maranhão, Hélcio |
author_sort | Costa Gomes, Rosane |
collection | PubMed |
description | Objective: The objective of this study is to investigate the occurrence of gastrointestinal (GI) and extraintestinal symptoms in children and adolescents with type 1 diabetes mellitus (DM1) and Down syndrome (DS) and their association with specific antibodies and histopathology of celiac disease (CelD), representing its clinical forms in the iceberg. Material and methods: Cross-sectional study (November 2009–December 2012) conducted at an outpatient care facility in Northeast Brazil including patients [DM1 (n = 111); DS (n = 77)] aged 10 months–18 years old. Measurement of anti-endomysial (EmA) and anti-tissue transglutaminase (anti-tTG) IgA antibodies was performed, as was that of anti-tTG-IgG in the cases with low serum IgA. The patients with antibody positivity were subjected to small intestine biopsy. Results: GI symptoms occurred in 53.7% of the sample, extraintestinal symptoms in 4.3%, and antibody positivity in 28.2% (n = 53). Of those who underwent biopsy (n = 40), histopathological findings of CelD were found in 37.5% [DM1 = 5/111 (4.5%), DS = 10/77 (13.0%)]. GI symptoms were associated with antibody positivity, but not with the histopathology. The GI (32.5%), silent (5.0%), and potential (62.5%) forms of disease were detected. Conclusions: The prevalence of GI symptoms was high in groups DM1 and DS, and the occurrence of such symptoms was associated with antibody positivity. The lack of association between the symptoms and histopatholological findings points to the inconsistency of the former as indicators of CelD. Although the GI form predominated among the cases with active CelD, its contribution to the celiac iceberg was smaller compared with the potential form, which determined the large and submerged base of the iceberg representing the high-risk groups investigated. |
format | Online Article Text |
id | pubmed-4732421 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Informa Healthcare |
record_format | MEDLINE/PubMed |
spelling | pubmed-47324212016-02-16 The celiac iceberg: from the clinical spectrum to serology and histopathology in children and adolescents with type 1 diabetes mellitus and Down syndrome Costa Gomes, Rosane Cerqueira Maia, Jussara Fernando Arrais, Ricardo André Nunes Jatobá, Carlos Auxiliadora Carvalho Rocha, Maria Edinilma Felinto Brito, Maria Laissa Oliveira Nazion, Ana Marques Maranhão, Clarissa De Sousa Maranhão, Hélcio Scand J Gastroenterol Original Article Objective: The objective of this study is to investigate the occurrence of gastrointestinal (GI) and extraintestinal symptoms in children and adolescents with type 1 diabetes mellitus (DM1) and Down syndrome (DS) and their association with specific antibodies and histopathology of celiac disease (CelD), representing its clinical forms in the iceberg. Material and methods: Cross-sectional study (November 2009–December 2012) conducted at an outpatient care facility in Northeast Brazil including patients [DM1 (n = 111); DS (n = 77)] aged 10 months–18 years old. Measurement of anti-endomysial (EmA) and anti-tissue transglutaminase (anti-tTG) IgA antibodies was performed, as was that of anti-tTG-IgG in the cases with low serum IgA. The patients with antibody positivity were subjected to small intestine biopsy. Results: GI symptoms occurred in 53.7% of the sample, extraintestinal symptoms in 4.3%, and antibody positivity in 28.2% (n = 53). Of those who underwent biopsy (n = 40), histopathological findings of CelD were found in 37.5% [DM1 = 5/111 (4.5%), DS = 10/77 (13.0%)]. GI symptoms were associated with antibody positivity, but not with the histopathology. The GI (32.5%), silent (5.0%), and potential (62.5%) forms of disease were detected. Conclusions: The prevalence of GI symptoms was high in groups DM1 and DS, and the occurrence of such symptoms was associated with antibody positivity. The lack of association between the symptoms and histopatholological findings points to the inconsistency of the former as indicators of CelD. Although the GI form predominated among the cases with active CelD, its contribution to the celiac iceberg was smaller compared with the potential form, which determined the large and submerged base of the iceberg representing the high-risk groups investigated. Informa Healthcare 2016-02-01 2015-09-04 /pmc/articles/PMC4732421/ /pubmed/26339731 http://dx.doi.org/10.3109/00365521.2015.1079645 Text en © 2015 The Author(s). Published by Taylor & Francis. http://creativecommons.org/Licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/Licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way. |
spellingShingle | Original Article Costa Gomes, Rosane Cerqueira Maia, Jussara Fernando Arrais, Ricardo André Nunes Jatobá, Carlos Auxiliadora Carvalho Rocha, Maria Edinilma Felinto Brito, Maria Laissa Oliveira Nazion, Ana Marques Maranhão, Clarissa De Sousa Maranhão, Hélcio The celiac iceberg: from the clinical spectrum to serology and histopathology in children and adolescents with type 1 diabetes mellitus and Down syndrome |
title | The celiac iceberg: from the clinical spectrum to serology and histopathology in children and adolescents with type 1 diabetes mellitus and Down syndrome |
title_full | The celiac iceberg: from the clinical spectrum to serology and histopathology in children and adolescents with type 1 diabetes mellitus and Down syndrome |
title_fullStr | The celiac iceberg: from the clinical spectrum to serology and histopathology in children and adolescents with type 1 diabetes mellitus and Down syndrome |
title_full_unstemmed | The celiac iceberg: from the clinical spectrum to serology and histopathology in children and adolescents with type 1 diabetes mellitus and Down syndrome |
title_short | The celiac iceberg: from the clinical spectrum to serology and histopathology in children and adolescents with type 1 diabetes mellitus and Down syndrome |
title_sort | celiac iceberg: from the clinical spectrum to serology and histopathology in children and adolescents with type 1 diabetes mellitus and down syndrome |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4732421/ https://www.ncbi.nlm.nih.gov/pubmed/26339731 http://dx.doi.org/10.3109/00365521.2015.1079645 |
work_keys_str_mv | AT costagomesrosane theceliacicebergfromtheclinicalspectrumtoserologyandhistopathologyinchildrenandadolescentswithtype1diabetesmellitusanddownsyndrome AT cerqueiramaiajussara theceliacicebergfromtheclinicalspectrumtoserologyandhistopathologyinchildrenandadolescentswithtype1diabetesmellitusanddownsyndrome AT fernandoarraisricardo theceliacicebergfromtheclinicalspectrumtoserologyandhistopathologyinchildrenandadolescentswithtype1diabetesmellitusanddownsyndrome AT andrenunesjatobacarlos theceliacicebergfromtheclinicalspectrumtoserologyandhistopathologyinchildrenandadolescentswithtype1diabetesmellitusanddownsyndrome AT auxiliadoracarvalhorochamaria theceliacicebergfromtheclinicalspectrumtoserologyandhistopathologyinchildrenandadolescentswithtype1diabetesmellitusanddownsyndrome AT edinilmafelintobritomaria theceliacicebergfromtheclinicalspectrumtoserologyandhistopathologyinchildrenandadolescentswithtype1diabetesmellitusanddownsyndrome AT laissaoliveiranazionana theceliacicebergfromtheclinicalspectrumtoserologyandhistopathologyinchildrenandadolescentswithtype1diabetesmellitusanddownsyndrome AT marquesmaranhaoclarissa theceliacicebergfromtheclinicalspectrumtoserologyandhistopathologyinchildrenandadolescentswithtype1diabetesmellitusanddownsyndrome AT desousamaranhaohelcio theceliacicebergfromtheclinicalspectrumtoserologyandhistopathologyinchildrenandadolescentswithtype1diabetesmellitusanddownsyndrome AT costagomesrosane celiacicebergfromtheclinicalspectrumtoserologyandhistopathologyinchildrenandadolescentswithtype1diabetesmellitusanddownsyndrome AT cerqueiramaiajussara celiacicebergfromtheclinicalspectrumtoserologyandhistopathologyinchildrenandadolescentswithtype1diabetesmellitusanddownsyndrome AT fernandoarraisricardo celiacicebergfromtheclinicalspectrumtoserologyandhistopathologyinchildrenandadolescentswithtype1diabetesmellitusanddownsyndrome AT andrenunesjatobacarlos celiacicebergfromtheclinicalspectrumtoserologyandhistopathologyinchildrenandadolescentswithtype1diabetesmellitusanddownsyndrome AT auxiliadoracarvalhorochamaria celiacicebergfromtheclinicalspectrumtoserologyandhistopathologyinchildrenandadolescentswithtype1diabetesmellitusanddownsyndrome AT edinilmafelintobritomaria celiacicebergfromtheclinicalspectrumtoserologyandhistopathologyinchildrenandadolescentswithtype1diabetesmellitusanddownsyndrome AT laissaoliveiranazionana celiacicebergfromtheclinicalspectrumtoserologyandhistopathologyinchildrenandadolescentswithtype1diabetesmellitusanddownsyndrome AT marquesmaranhaoclarissa celiacicebergfromtheclinicalspectrumtoserologyandhistopathologyinchildrenandadolescentswithtype1diabetesmellitusanddownsyndrome AT desousamaranhaohelcio celiacicebergfromtheclinicalspectrumtoserologyandhistopathologyinchildrenandadolescentswithtype1diabetesmellitusanddownsyndrome |